Valid dementia verdict? Nursing home and hospital diagnoses now better aligned, study finds
By
Alicia Lasek
May 03, 2021
Medicare’s dementia claim measures appear to have become more sensitive in recent years, agreeing more closely with hospital-based measures overall and for certain populations than in the past, investigators...
FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
New behavior management guidelines support person-centered dementia care
By
Alicia Lasek
Nov 18, 2020
Properly addressing the distress that underlies dementia-related behaviors is key to improving quality of life and preventing rapid decline in these patients, according to new guidance from leading dementia...
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.
SNF residents avoid repeat hospitalization with nurse-led heart failure program
By
Alicia Lasek
Sep 03, 2021
Sixty days after admission, patients in the disease management program had a lower composite rate of rehospitalization, ED visits or mortality when compared with their peers who had usual care. The program...
While FDA moves to halt mask reuse, N95 access remains spotty, report finds
By
Alicia Lasek
Apr 15, 2021
A new push to ensure that healthcare facilities stockpile single-use or reusable N95 respirators has arrived while some workers continue to lack access to the equipment and U.S. mask manufacturers can’t...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Thyroid hormone treatment for older adults may do more harm than good, study finds
By
Alicia Lasek
Apr 08, 2020
Hormone replacement therapy almost doubles the mortality risk in seniors with subclinical hypothyroidism compared to those who do not take hormones.
Dementia toolkit for clinicians underscores urgency of early diagnosis
By
Alicia Lasek
Mar 31, 2021
A primary care toolkit for brain health assessment and dementia diagnosis has gotten a much-needed update as more research points to the potential for better outcomes with earlier diagnoses, the authors...